Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activity
- 31 December 1979
- journal article
- Published by Elsevier in Prostaglandins and Medicine
- Vol. 3 (6), 327-332
- https://doi.org/10.1016/0161-4630(79)90025-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Reversible and irreversible inhibition of platelet cyclooxygenase and serotonin release by nonsteroidal antiinflammatory drugsThrombosis Research, 1978
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978
- Sulfinpyrazone in the Prevention of Cardiac Death after Myocardial InfarctionNew England Journal of Medicine, 1978
- Aspirin Prophylaxis of Venous Thromboembolism after Total Hip ReplacementNew England Journal of Medicine, 1977
- Synthesis of prostaglandin D2 and thromboxane B2 by human plateletsThrombosis Research, 1977
- Controlled trial of aspirin in cerebral ischemia.Stroke, 1977
- Aspirin as a quantitative acetylating reagent for the fatty acid oxygenase that forms prostaglandinsProstaglandins, 1976
- Aspirin Selectively Inhibits Prostaglandin Production in Human PlateletsNature New Biology, 1971
- EFFECT OF ANTI-INFLAMMATORY AGENTS ON PLATELETSThe Lancet, 1968
- Acetylsalicylic acid hydrolysis in human blood and plasma I. Methodology and in vitro studiesJournal of Pharmaceutical Sciences, 1967